Ascendia Pharmaceutical Solutions Founder and CEO Named EY Entrepreneur Of The Year® 2026 New Jersey Finalist

Apr 24, 2026, 6:14:51 PM

PROTACS – A New Generation of Poorly Soluble and Permeable Molecules for Targeting Proteins

Mar 4, 2026, 12:45:33 PM

Long-Acting Injectable Drugs: How Nanoparticles Help Overcome Challenges

Feb 16, 2026, 4:56:24 PM

PLGA: A Versatile Copolymer for Nanoparticle Design & Development

Jan 2, 2026, 5:29:48 PM

Overcoming Oral Drug Development Challenges

Dec 11, 2025, 2:52:40 PM

Ascendia Pharmaceutical Solutions Provides Forum to Advance Drug Development

Oct 30, 2025, 3:40:54 PM

Ascendia Pharmaceutical Solutions to Host 3rd Annual Technical Workshop to Advance Drug Development

Sep 4, 2025, 5:31:19 PM

Lipid Nanoparticles – Antibody-Drug Conjugates (ADCs)

Jul 21, 2025, 5:57:24 PM

Lyophilization: An Enabling Technology to Enhance Drug Stability and Performance

Jul 3, 2025, 3:05:28 PM

Nanoparticles Enable Nose to Brain Drug Delivery

Jun 3, 2025, 1:20:31 PM

SEDDS/SNEDDS – A Self Emulsifying Technology for Delivery of an Array of Small and Large Molecules

Apr 29, 2025, 1:05:33 PM

Clinical Trial Materials Manufacturing from Ascendia Pharmaceutical Solutions

Apr 16, 2025, 1:51:33 PM